Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

F. Zhan · SciRah

Researcher profile · Semantic Scholar

F. Zhan

Share profile

F. Zhan — researcher profile on SciRah

h-index: 17
Works: 38
Citations: 1,214

Most-cited papers

Sequential biochemotherapy versus chemotherapy for metastatic melanoma: results from a phase III randomized trial.
O. Eton, S. Legha, A. Bedikian, J. Lee +8 more
2002Journal of Clinical Oncology358 citations
Semantic Scholar
Sunitinib malate for metastatic castration-resistant prostate cancer following docetaxel-based chemotherapy.
G. Sonpavde, P. Periman, D. Bernold, D. Weckstein +7 more
2010Annals of Oncology124 citations Open access
Semantic Scholar
A Phase III trial of fludarabine, cyclophosphamide, and rituximab vs. pentostatin, cyclophosphamide, and rituximab in B-cell chronic lymphocytic leukemia
C. Reynolds, N. Dibella, R. Lyons, W. Hyman +6 more
2012Investigational new drugs75 citations
Semantic Scholar
Phase III trial of cetuximab, bevacizumab, and 5-fluorouracil/leucovorin vs. FOLFOX-bevacizumab in colorectal cancer.
L. Saltz, S. Badarinath, S. Dakhil, B. Bienvenu +16 more
2012Clinical colorectal cancer73 citations
Semantic Scholar
Azacitidine favorably modulates PSA kinetics correlating with plasma DNA LINE-1 hypomethylation in men with chemonaïve castration-resistant prostate cancer.
G. Sonpavde, A. Aparicio, F. Zhan, B. North +11 more
2011Urologic oncology67 citations
Semantic Scholar
Administration of cisplatin-based chemotherapy for advanced urothelial carcinoma in the community.
G. Sonpavde, D. Watson, Marcia Tourtellott, C. Cowey +4 more
2012Clinical Genitourinary Cancer61 citations
Semantic Scholar
Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: Results of a Phase II, randomized, noncomparative study
D. Richards, P. Kuefler, C. Becerra, Lalan S. Wilfong +11 more
2011Investigational new drugs54 citations
Semantic Scholar
Results of a Randomized Phase II Trial of Pegfilgrastim Versus Filgrastim To Treat Neutropenia Post-Autologous Peripheral Blood Stem Cell Transplant (PBSCT) in Patients with Non-Hodgkin’s Lymphoma (NHL).
R. Rifkin, R. Beveridge, G. Spitzer, G. Orloff +6 more
200748 citations
Semantic Scholar
Results of docetaxel plus oxaliplatin (DOCOX) ± cetuximab in patients with metastatic gastric and/or gastroesophageal junction adenocarcinoma: results of a randomised Phase 2 study.
D. Richards, D. Kocs, A. Spira, A. McCollum +5 more
2013European Journal of Cancer46 citations
Semantic Scholar
Phase II trial of gemcitabine/carboplatin (plus trastuzumab in HER2-positive disease) in patients with metastatic breast cancer.
D. Loesch, L. Asmar, K. McIntyre, Lisa L. Doane +8 more
2008Clinical Breast Cancer45 citations
Semantic Scholar
Phase II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer and/or adenocarcinoma of the gastroesophageal junction.
D. Richards, D. McCollum, Lalan S. Wilfong, M. Sborov +3 more
2008Annals of Oncology36 citations Open access
Semantic Scholar
Pemetrexed in Relapsed Small-Cell Lung Cancer and the Impact of Shortened Vitamin Supplementation Lead-In Time: Results of a Phase II Trial
M. Socinski, R. Raju, M. Neubauer, David A. Smith +8 more
2008Journal of Thoracic Oncology29 citations Open access
Semantic Scholar
Sunitinib malate for metastatic castration resistant prostate cancer following docetaxel-based chemotherapy
P. Periman, G. Sonpavde, D. Bernold, D. Weckstein +5 more
200827 citations
Semantic Scholar
Phase III multicenter trial of doxorubicin plus cyclophosphamide followed by paclitaxel compared with doxorubicin plus paclitaxel followed by weekly paclitaxel as adjuvant therapy for women with high-risk breast cancer.
D. Loesch, F. Greco, Neil Senzer, H. Burris +15 more
2010Journal of Clinical Oncology26 citations Open access
Semantic Scholar
Cost Effectiveness of Imatinib, Dasatinib, and Nilotinib as First-Line Treatment for Chronic-Phase Chronic Myeloid Leukemia in China
Na Li, B. Zheng, Hongfu Cai, Jing Yang +4 more
2017Clinical drug investigation24 citations
Semantic Scholar
Pegfilgrastim appears equivalent to daily dosing of filgrastim to treat neutropenia after autologous peripheral blood stem cell transplantation in patients with non-Hodgkin lymphoma.
R. Rifkin, G. Spitzer, G. Orloff, R. Mandanas +5 more
2010Clinical Lymphoma, Myeloma & Leukemia19 citations
Semantic Scholar
Results of a phase II study of pemetrexed as first-line chemotherapy in patients with advanced or metastatic breast cancer
N. Robert, P. Conkling, M. O'Rourke, P. Kuefler +6 more
2011Breast Cancer Research and Treatment16 citations
Semantic Scholar
Dynamics of neutrophil-to-lymphocyte ratio predict outcomes of metastatic colorectal carcinoma patients treated by FOLFOX.
Qian Liu, Yan-Feng Xi, Guangzhao He, Xiaoqian Li +1 more
2021Journal of Gastrointestinal Oncology14 citations Open access
Semantic Scholar
Sunitinib malate in previously untreated, nonsquamous, non-small cell lung cancer patients over the age of 70 years: Results of a Phase II trial
C. Reynolds, A. Spira, L. Gluck, S. Mueller +3 more
2013Investigational new drugs13 citations
Semantic Scholar
Phase III Trial of Fludarabine, Cyclophosphamide, and Rituximab Vs. Pentostatin, Cyclophosphamide, and Rituximab in B-Cell Chronic Lymphocytic Leukemia
C. Reynolds, N. Dibella, R. Lyons, W. Hyman +7 more
200810 citations
Semantic Scholar
Results of docetaxel plus oxaliplatin (DOCOX) with or without cetuximab in patients with metastatic gastric and/or gastroesophagel junction adenocarcinoma: Results of a randomized phase II study.
Donald A. Richards, Darren M. Kocs, A. Spira, A. McCollum +3 more
2011Journal of Clinical Oncology9 citations
Semantic Scholar
Phase II multicenter trial of docetaxel+oxaliplatin in stage IV gastroesophageal and/or stomach cancer.
Donald A. Richards, Lalan S. Wilfong, D. Reznick, D. McCollum +3 more
2006Journal of Clinical Oncology8 citations
Semantic Scholar
Azacitidine for castration-resistant prostate cancer progressing on combined androgen blockade
G. Sonpavde, A. Aparicio, R. Delaune, L. Garbo +7 more
20086 citations
Semantic Scholar
Phase II study of low dose (weekly) docetaxel and estramustine in elderly males (age ≥75 years) with hormone-refractory prostate cancer or patients age 18 to 74 years with an ECOG performance status of 2 or 3
S. Chittoor, W. Berry, D. Loesch, K. Logie +5 more
20056 citations
Semantic Scholar
A phase II open-label trial of bortezomib in patients with multiple myeloma who have undergone an autologous peripheral blood stem cell transplant and failed to achieve a complete response
R. Rifkin, A. Greenspan, J. Schwerkoske, R. Mandanas +6 more
2012Investigational new drugs5 citations
Semantic Scholar
Phase II study of low-dose docetaxel/estramustine in elderly patients or patients aged 18-74 years with hormone-refractory prostate cancer.
S. Chittoor, W. Berry, D. Loesch, K. Logie +5 more
2006Clinical Genitourinary Cancer5 citations
Semantic Scholar
Frequency of cisplatin administration in patients presenting with advanced urothelial carcinoma in the community.
G. Sonpavde, D. Watson, Marcia Tourtellott, E. Higgins +5 more
2012Journal of Clinical Oncology3 citations
Semantic Scholar
P5-18-09: The Incidence of Febrile Neutropenia in the First Course of Adjuvant Chemotherapy with Docetaxel/Cyclophosphamide with or without Pegfilgrastim.
S. Jones, D. Paul, S. Sedlacek, S. Vukelja +11 more
20113 citations
Semantic Scholar
Results of a phase II study of single-agent sunitinib in elderly non-small cell lung cancer patients.
C. Reynolds, A. Spira, W. L. Gluck, R. Pluenneke +3 more
2011Journal of Clinical Oncology3 citations
Semantic Scholar
Three-Year Follow-Up of Survival and Progression in a Phase II Trial of Gemcitabine Plus Carboplatin (Plus Trastuzumab in HER2+ Patients) in Metastatic Breast Cancer Patients.
D. Loesch, L. Asmar, K. McIntyre, M. Orlando +3 more
20092 citations
Semantic Scholar
Results of a phase II study of pemetrexed as first-line chemotherapy for advanced or metastatic breast cancer
N. Robert, P. Conkling, P. Kuefler, K. McIntyre +5 more
20081 citations
Semantic Scholar
Two Weeks High Glucose is Enough to Induce Liver and Gut Lesion
Cun-Yun Min, Ting-Ting Fu, Yu Du, W. Tan +2 more
20210 citations Open access
Semantic Scholar
Erratum to: Sunitinib malate in previously untreated, nonsquamous, non-small cell lung cancer patients over the age of 70 years: Results of a Phase II trial
C. Reynolds, A. Spira, L. Gluck, Suzanne J. Bradie-Muller +3 more
2013Investigational new drugs0 citations Open access
Semantic Scholar
Frequency of cisplatin administration in patients presenting with advanced urothelial carcinoma in the community.
G. Sonpavde, D. Watson, Marcia Tourtellott, E. Higgins +5 more
2012Journal of Clinical Oncology0 citations
Semantic Scholar
Results of a Phase II Open-Label Trial of Bortezomib in Patients with Multiple Myeloma Who Have Undergone High-Dose Melphalan Therapy Followed by Autologous Peripheral Blood Stem Cell Transplantation and Failed to Achieve a Complete Response
R. Rifkin, G. Spitzer, A. Greenspan, J. Schwerkoske +6 more
20080 citations
Semantic Scholar
79: Pegfilgrastim (P) Appears to be Equivalent to Multiple Daily Doses of Filgrastim (F) to Treat Neutropenia Post-Autologous Peripheral Blood Stem Cell Transplant (PBSCT) in Patients with Non-Hodgkin's Lymphoma: Results of a Randomized Phase II Trial
R. Rifkin, R. Beveridge, G. Spitzer, G. Orloff +5 more
20080 citations Open access
Semantic Scholar
Interim Analysis of a Phase II Trial of Bortezomib in Patients with Multiple Myeloma Who Failed To Achieve a Complete Response to Autologous Peripheral Blood Stem Cell Transplantation.
R. Rifkin, R. Beveridge, M. Brunvand, G. Spitzer +4 more
20050 citations
Semantic Scholar
Phase II trial of GM-CSF as maintenance therapy post–autologous peripheral blood stem cell transplantation in multiple myeloma
R. Mandanas, R. Beveridge, R. Rifkin, A. Greenspan +6 more
20050 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

L. Asmar×25
Invite
L. Asmar — researcher profile on SciRah
K. Boehm×24
Invite
K. Boehm — researcher profile on SciRah
G. Sonpavde×7
Invite
G. Sonpavde — researcher profile on SciRah
R. Rifkin×7
Invite
R. Rifkin — researcher profile on SciRah

×7

Invite

R. Beveridge — researcher profile on SciRah

Invite

D. Richards — researcher profile on SciRah

Invite

R. Mandanas — researcher profile on SciRah

Invite

K. McIntyre — researcher profile on SciRah

Invite

G. Spitzer — researcher profile on SciRah

Invite

D. Loesch — researcher profile on SciRah

J. O'Shaughnessy×5

Invite

J. O'Shaughnessy — researcher profile on SciRah

Invite

W. Berry — researcher profile on SciRah